Examining ESPR’s book value per share for the latest quarter

Preston Campbell

Currently, Esperion Therapeutics Inc’s (ESPR) stock is trading at $2.77, marking a fall of -0.36% from last night’s close. At this price, the stock is -29.70% below its 52-week high of $3.94 and 300.00% above its 52-week low of $0.69.

How does Esperion Therapeutics Inc (ESPR) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.

Esperion Therapeutics Inc (ESPR): Earnings History

If we examine Esperion Therapeutics Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.02, slashing the consensus of -$0.16. In other words, it beat the consensus by $0.14, resulting in a 87.50% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.02 in contrast with the Outlook of -$0.16. That was a difference of $0.14 and a surprise of 87.50%.

Esperion Therapeutics Inc (NASDAQ: ESPR) Ownership Details

I will give a breakdown of the key shareholders in Esperion Therapeutics Inc (ESPR). Recent figures show that the company’s insiders hold 0.56% of shares. A total of 210 institutional investors hold shares in the company, making 50.62% of its stock and 50.90% of its float.

Jun 30, 2025, it was reported that the Company’s largest institutional holder is WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund holding total of 7.02 shares that make 3.48% of the company’s total number of shares and are currently priced at 19.59 million.

The securities firm VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds 6.18 shares of ESPR, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.06%, and the holding percentage of shares is valued at 17.24 million.

An overview of Esperion Therapeutics Inc’s technicals

Leave a Comment

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.